Vivek Subbiah, MD
@viveksubbiah
Chief, Early-Phase Drug Development|@SarahCannonDocs
#Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
ID: 3085571050
http://rb.gy/2h7jj 11-03-2015 03:24:25
28,28K Tweet
35,35K Followers
2,2K Following
🚨Hot of the press - Pleased to share our paper 👉🏼just before @esmo #ESMO24 👉🏼⭐️Huge congratulations to our early phase 1 clinical trials team Sarah Cannon Docs for the publication Journal of Clinical Oncology ASCO 👉🏼 First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate